Quick Answer
PULSE BIOSCIENCES, INC. reported Operating Income Loss of -$76.94 million for the year ending 2025.
- PULSE BIOSCIENCES, INC. showed a decrease of -36.8% in Operating Income Loss from 2024 to 2025.
- This data is from PULSE BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), PULSE BIOSCIENCES, INC.'s Operating Income Loss has declined by 1,622.0%.
- Historical annual values: Fiscal year 2025: -$76.94 million | Fiscal year 2024: -$56.26 million | Fiscal year 2023: -$43.57 million | Fiscal year 2022: -$58.06 million | Fiscal year 2021: -$63.01 million | Fiscal year 2020: -$49.97 million | Fiscal year 2019: -$47.95 million | Fiscal year 2018: -$37.55 million | Fiscal year 2017: -$25.57 million | Fiscal year 2016: -$9.52 million | Fiscal year 2015: -$4.47 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: